LENZ (lenzilumab) / Humanigen 
Welcome,         Profile    Billing    Logout  
 16 Diseases   3 Trials   3 Trials   683 News 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LENZ (lenzilumab) / Humanigen
ACTRN12620000844943: C-SMART. COVID-19 Prevention and Treatment in Cancer Arm 4: treatment among cancer patients with severe COVID-19 infection.

Withdrawn
3
72
 
Peter MacCallum Cancer Centre , Australian Government. Medical Research Future Fund
COVID-19, Cancer
 
 
NCT04351152: Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Checkmark Safety and efficacy data from LIVE-AIR study in COVID-19
Jul 2022 - Jul 2022: Safety and efficacy data from LIVE-AIR study in COVID-19
Active, not recruiting
3
520
US, RoW
Lenzilumab, Humaneered® anti-human GM-CSF monoclonal Antibody, Standard of Care
Humanigen, Inc.
Coronavirus Disease 2019 (COVID-19) Pneumonia
03/21
03/21
C-SMART, NCT04534725: COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;

Completed
3
441
RoW
Interferon alfa, Selinexor, Lenzilumab
Peter MacCallum Cancer Centre, Australia
Cancer, Covid19, Respiratory Viral Infection
11/22
04/23
ACTRN12621000223831p: Efficacy of assigning treatment for participants with Chronic Myelomonocytic Leukaemia based on their individual molecular results (lenzilumab plus azacitidine versus sodium ascorbate plus azacitidine).

Not yet recruiting
2
72
 
South Australian Health & Medical Research Institute Ltd, Medical Research Future Fund Grant, National Health and Medical Research Council.
Chronic Myelomonocytic Leukaemia
 
 
ACTRN12621000223831: Efficacy of assigning treatment for participants with Chronic Myelomonocytic Leukaemia based on their individual molecular results (lenzilumab plus azacitidine versus sodium ascorbate plus azacitidine).

Recruiting
2
54
 
South Australian Health & Medical Research Institute Ltd, Medical Research Future Fund Grant, National Health and Medical Research Council.
Chronic Myelomonocytic Leukaemia
 
 

Download Options